Create Free Account

By creating account you will get access to hot stocks & personalised emails

Integral Diagnostics Ltd

Healthcare AU IDX

2.43AUD
-0.03(1.22%)

Last update at 2024-05-02T06:10:00Z

Day Range

2.422.48
LowHigh

52 Week Range

1.623.46
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax 30.63M 22.56M 45.22M 35.26M 30.62M
Minority interest - - - - -
Net income 25.04M 14.60M 31.27M 23.03M 23.03M
Selling general administrative 285.58M 227.00M 207.56M 161.20M 146.12M
Selling and marketing expenses - - - - -
Gross profit 419.06M 339.52M 331.79M 261.60M 220.56M
Reconciled depreciation 43.49M 36.70M 34.91M 25.68M 13.51M
Ebit 49.00M 33.04M 54.13M 43.82M 36.81M
Ebitda 92.48M 69.74M 89.04M 69.50M 50.32M
Depreciation and amortization 43.49M 36.70M 34.91M 25.68M 13.51M
Non operating income net other - - - - -
Operating income 39.83M 38.62M 49.37M 38.43M 36.81M
Other operating expenses 201.74M 149.74M 146.66M 120.66M 194.52M
Interest expense 18.36M 10.48M 8.91M 8.56M 6.19M
Tax provision 5.59M 7.96M 13.95M 12.23M 9.63M
Interest income 18.20M 0.04M 0.09M 7.87M 4.46M
Net interest income -17.94200M -10.44400M -8.82100M -8.55900M -5.92200M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 5.59M 7.96M 13.95M 12.23M 9.63M
Total revenue 440.10M 358.74M 348.81M 274.08M 230.99M
Total operating expenses 379.92M 303.09M 277.61M 214.42M 184.09M
Cost of revenue 21.04M 19.22M 17.02M 12.48M 10.43M
Total other income expense net 9.44M -3.42700M -0.13400M -3.62800M -6.19400M
Discontinued operations - - - - -
Net income from continuing ops 25.04M 14.60M 31.27M 23.03M 20.98M
Net income applicable to common shares 25.04M 14.60M 31.27M 23.03M 20.98M
Preferred stock and other adjustments - - - - -
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Total assets 839.01M 783.01M 654.90M 580.47M 314.67M
Intangible assets 30.30M 28.02M 28.94M 27.25M 18.14M
Earning assets - - - - -
Other current assets 2.47M 1.70M 2.25M 4.43M 1.55M
Total liab 465.96M 435.77M 400.16M 352.13M 187.45M
Total stockholder equity 373.05M 347.24M 254.74M 228.33M 127.22M
Deferred long term liab - - - - -
Other current liab 7.48M 16.38M 15.86M 6.94M 25.14M
Common stock 333.28M 322.54M 219.22M 207.44M 109.51M
Capital stock 333.28M 322.54M 219.22M 207.44M 109.51M
Retained earnings 49.56M 37.16M 44.40M 31.69M 28.78M
Other liab 34.89M 31.99M 30.88M 27.28M 19.26M
Good will 444.48M 352.46M 315.79M 273.60M 184.11M
Other assets 19.03M 17.25M 16.34M 13.61M 7.80M
Cash 33.85M 123.19M 62.20M 57.97M 20.97M
Cash and equivalents - - - - -
Total current liabilities 82.67M 80.00M 77.90M 69.80M 38.83M
Current deferred revenue 48.11M 37.72M 40.31M 35.52M -
Net debt 331.22M 217.80M 246.15M 219.88M 118.08M
Short term debt 16.67M 17.21M 16.97M 22.79M 8.93M
Short long term debt 2.45M 5.47M 6.54M 13.18M 0.02M
Short long term debt total 365.08M 340.99M 308.35M 277.85M 139.05M
Other stockholder equity -382.83600M -359.69900M -263.62200M -239.13000M -11.07000M
Property plant equipment 282.46M 231.13M 211.49M 189.58M 70.78M
Total current assets 62.74M 153.98M 82.25M 76.43M 33.83M
Long term investments 0.01M 0.16M 0.10M - -
Net tangible assets -101.72400M -33.24300M -89.99000M -72.52400M -75.03400M
Short term investments 0.38M 0.38M 0.34M 0.40M 0.30M
Net receivables 21.69M 19.41M 14.26M 10.38M 9.03M
Long term debt 221.14M 217.58M 192.19M 157.00M 122.88M
Inventory 1.85M 1.26M 0.91M 1.00M 0.39M
Accounts payable 10.41M 8.69M 4.75M 4.54M 4.76M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -9.78800M -12.45500M -8.88300M -10.80000M -11.07000M
Additional paid in capital - - - - -
Common stock total equity - - - 207.44M 109.51M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - -496.84700M 280.83M
Deferred long term asset charges - - - - -
Non current assets total 776.27M 629.03M 572.65M 504.04M 280.83M
Capital lease obligations 141.48M 117.94M 109.63M 96.11M 16.17M
Long term debt total 348.41M 323.78M 291.38M 255.06M 130.12M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -128.95800M -55.69300M -56.66300M -93.53300M -94.97200M
Change to liabilities 1.40M -0.21300M -1.13700M 2.13M 0.34M
Total cashflows from investing activities -128.95800M -55.69300M -56.66300M -93.53300M -94.97200M
Net borrowings -21.41200M 13.04M 8.40M 23.45M 74.03M
Total cash from financing activities -31.84900M 81.13M -7.83400M 75.40M 61.53M
Change to operating activities 5.55M 0.70M 6.57M -1.12200M 1.25M
Net income 25.04M 14.60M 31.27M 23.03M 20.98M
Change in cash -89.33800M 60.99M 4.24M 37.00M 0.12M
Begin period cash flow 123.19M 62.20M 57.97M 20.97M 20.84M
End period cash flow 33.85M 123.19M 62.20M 57.97M 20.97M
Total cash from operating activities 71.42M 37.10M 69.57M 54.25M 32.68M
Issuance of capital stock 2.20M 91.83M 1.79M 73.48M 1.58M
Depreciation 43.49M 36.70M 34.91M 25.68M 13.51M
Other cashflows from investing activities -84.96300M -27.92300M -36.40400M -67.65700M -76.30300M
Dividends paid -12.64000M -20.86300M -17.88600M -18.02900M 14.03M
Change to inventory - - - - -
Change to account receivables -0.35200M -3.43600M -2.91800M -1.71100M -1.99000M
Sale purchase of stock 43.05M 114.15M -0.13900M -3.50900M 131.06M
Other cashflows from financing activities -19.25200M -14.15500M 25.18M 26.11M -0.05200M
Change to netincome -9.44700M -2.46000M 1.25M 2.59M -1.41700M
Capital expenditures 43.99M 27.77M 20.27M 25.88M 18.67M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.35200M -3.43600M -2.91800M -1.71100M -53.22600M
Stock based compensation 2.54M -1.20843M 2.08M 1.34M -
Other non cash items 2.89M -14.20200M 3.39M 5.54M -34.49200M
Free cash flow 27.42M 9.33M 49.30M 28.37M 14.01M

Fundamentals

  • Previous Close 2.46
  • Market Cap568.53M
  • Volume336535
  • P/E Ratio-
  • Dividend Yield2.06%
  • EBITDA71.01M
  • Revenue TTM456.31M
  • Revenue Per Share TTM1.96
  • Gross Profit TTM 143.76M
  • Diluted EPS TTM-0.25

Peer Comparison

Sector: Healthcare Industry: Diagnostics & Research

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
IDX
Integral Diagnostics Ltd		 -0.03 1.22% 2.43 - 19.12 1.22 1.85 1.97 71.46
SHL
Sonic Healthcare Ltd		 -0.41 1.56% 25.94 24.24 17.92 1.55 1.69 1.96 10.59
HLS
Healius Ltd		 -0.05 4.35% 1.10 - 21.10 0.52 0.84 1.43 -3.5527
MVF
Monash IVF Group Ltd		 0.005 0.34% 1.46 24.42 - 2.40 2.05 2.89 13.15
ACL
Australian Clinical Labs Ltd		 -0.01 0.41% 2.41 30.13 13.35 0.75 3.09 1.22 5.27

Reports Covered

Stock Research & News

View All

Profile

Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. It provides services through 67 radiology clinics. The company was incorporated in 2008 and is headquartered in Melbourne, Australia.

Integral Diagnostics Ltd

45 William Street, Melbourne, VIC, Australia, 3000

Key Executives

Name Title Year Born
Dr. Ian Kadish M.B.A., MBBCh, MBA CEO, MD & Director 1963
Mr. Craig White Chief Financial Officer NA
Mr. Paul McCrow Chief Operating Officer NA
Dr. Jacqueline Milne MBBS Exec. Director NA
Dr. Nazar Bokani M.D. Non-Independent Exec. Director NA
Mr. Julian Gully Chief Information Officer NA
Ms. Mica Duncalfe Chief People Officer NA
Dr. Lisa Sorger MBBS Chief Medical Officer NA
Ms. Kirsty Lally B.Com., C.A. Company Sec. NA
Dr. Ian Kadish M.B.A., MBBCh CEO, MD & Director 1963

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).

Our Company

Useful Links

Contact Us

Market Research

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.